What You Should Know
Oncology AI innovator Triomics has announced a $22M Series B financing round led by Battery Ventures, pushing its total venture funding past $36 million.The expansion round features strategic backing from Lightspeed, Nexus Venture Partners, Y Combinator, Oncology Ventures,
Read More
Triomics Secures $22M to Automate Oncology AI Chart Abstraction
































































